News from IDF Europe

Survey on access to diabetes care in Europe: all translations now available

Following the launch the IDF Europe survey on Access to medicines and medical devices for diabetes care in Europe, the 3 questionnaires for people with diabetes, health care professionals and institutions are now available in all language versions. Click here to access all the questionnaires!

IDF Europe launches survey on access to medicines and medical devices for diabetes care in Europe

!! The online questionnaires have been closed. If you wish to further contribute to the survey, please contact Elodie Besnier at Elodie@idf-europe.org !!

European Medicines Agency publishes list of medicines under additional monitoring

The European Medicines Agency has published today the initial list of medicines subject to additional monitoring. This represents an important deliverable of the new European pharmacovigilance legislation. These medicines will have to display an inverted back triangle in their package leaflet and in the information for healthcare professionals called the summary of product characteristics (SmPC), together with a short sentence explaining what the triangle means.

Public consultation on World Medical Association’s Declaration of Helsinki

The World Medical Association (WMA) has opened a two-month consultation on its Helsinki Declaration on medical research involving human subjects.

WMA invites all interested stakeholders to comment on the proposed changes to the text, which revised version has been posted on the WMA website. All experts and stakeholders are invited to submit their comments to the WMA secretariat no later than 15 June 2013.

Latest news from the European Patients' Academy on therapeutic innovation

EUPATI - the European Patients' Academy on Therapeutic Innovation, has just published its newsletter for the second quarter of 2013. 

IDF Europe joins European project on economics of chronic diseases

EConDA, Economics of Chronic Diseases: this is the name of a European project aiming to examine the best method for assessing cost-effectiveness of interventions to prevent chronic diseases.

Apply for the 2013 Youth Leadership Camp!

If want to meet other young people living with diabetes from all over Europe, share and learn from each other and discover more about the work of IDF Europe, then the Youth Leadership Camp is for you!

To build up on the success of the initiative, IDF Europe will organize the 3rd edition of its Youth Leadership Camp from 22 to 28 July 2013 in Tirrenia, Italy.

Pharmacovigilance: New black triangle symbol for medicines subject to additional monitoring

A black inverted triangle '▼' will shortly appear on the package leaflet of certain medicinal products on the EU market, following an Implementing Regulation adopted by the European Commission today. This symbol will flag to patients and health care professionals that a medicinal product is subject to additional monitoring, and its accompanying text will encourage them to report any unexpected adverse reaction through national reporting systems.

IDF Europe position on EU Regulation on Medical Devices

IDF Europe has published its position on the European Commission proposal for a Regulation on Medical Devices.

February 2013 News Update

Our latest News Update is here!

Find out more about the latest developments in diabetes and health policy and advocacy in Europe.

Enjoy the read!


Pages